CN Patent

CN102666528A — 晶体cdc7 抑制剂盐

Assigned to Nerviano Medical Sciences SRL · Expires 2012-09-12 · 14y expired

What this patent protects

本发明涉及CDC7或CDC7/CDK抑制剂的新晶体盐，相应游离碱的新晶形，其制备方法，这些新的盐形式的水合物、溶剂化物和多晶型，及其在治疗中的用途、以及含有其的药物组合物。这些晶体盐选自5-(2-氨基-嘧啶-4-基)-2-(2,4-二氯-苯基)-1H-吡咯-3-甲酰胺的L-天冬氨酸、半延胡索酸盐、盐酸盐、马来酸盐、甲磺酸盐、硫酸盐、L-天冬氨酸盐或磷酸盐。

USPTO Abstract

本发明涉及CDC7或CDC7/CDK抑制剂的新晶体盐，相应游离碱的新晶形，其制备方法，这些新的盐形式的水合物、溶剂化物和多晶型，及其在治疗中的用途、以及含有其的药物组合物。这些晶体盐选自5-(2-氨基-嘧啶-4-基)-2-(2,4-二氯-苯基)-1H-吡咯-3-甲酰胺的L-天冬氨酸、半延胡索酸盐、盐酸盐、马来酸盐、甲磺酸盐、硫酸盐、L-天冬氨酸盐或磷酸盐。

Drugs covered by this patent

Patent Metadata

Patent number
CN102666528A
Jurisdiction
CN
Classification
—
Expires
2012-09-12
Drug substance claim
No
Drug product claim
No
Assignee
Nerviano Medical Sciences SRL
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.